Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4126
Blue Ridge Bankshares
BRBS
$347M
| $406K | ﹤0.01% |
113,000
| – | – |
2024 Q4
2 quarters
|
|
|
EDF
4127
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$156M
| $406K | ﹤0.01% |
80,315
+4,375
| +6% | +$21.3K |
2024 Q4
2 quarters
|
|
|
IBMT
4128
iShares iBonds Dec 2031 Term Muni Bond ETF
IBMT
$155M
| $405K | ﹤0.01% |
+15,961
| New | +$400K |
2025 Q2
0 quarters
|
|
4129
ImmunityBio
IBRX
$9.84B
| $404K | ﹤0.01% |
153,060
+68,956
| +82% | +$185K |
2024 Q4
2 quarters
|
|
|
TEAF
4130
DELISTED
Ecofin Sustainable & Social Impact Term Fund
TEAF
| $404K | ﹤0.01% |
32,963
-7,710
| -19% | -$88.3K |
2024 Q4
2 quarters
|
|
4131
iShares iBonds 2030 Term High Yield and Income ETF
IBHJ
$179M
| $403K | ﹤0.01% |
15,142
+2,520
| +20% | +$65.6K |
2024 Q4
2 quarters
|
|
4132
Westlake Corp
WLK
$7.98B
| $402K | ﹤0.01% |
5,298
-107,647
| -95% | -$8.81M |
2024 Q4
2 quarters
|
|
4133
State Street Fixed Income Sector Rotation ETF
FISR
$598M
| $401K | ﹤0.01% |
15,511
-29
| -0.2% | -$740 |
2024 Q4
2 quarters
|
|
4134
Editas Medicine
EDIT
$387M
| $401K | ﹤0.01% |
182,118
-15,348
| -8% | -$25.1K |
2024 Q4
2 quarters
|
|
4135
Goosehead Insurance
GSHD
$1.12B
| $400K | ﹤0.01% |
3,791
-5,567
| -59% | -$590K |
2024 Q4
2 quarters
|
|
|
SARO
4136
PUT
StandardAero Inc
SARO
$7.01B
| $400K | ﹤0.01% |
20,000
| – | – |
2025 Q1
1 quarter
|
|
4137
Phreesia
PHR
$643M
| $400K | ﹤0.01% |
14,049
+375
| +3% | +$9.52K |
2024 Q4
2 quarters
|
|
4138
ProShares UltraPro QQQ
TQQQ
$38.3B
| $399K | ﹤0.01% |
9,624
+750
| +8% | +$23.7K |
2024 Q4
2 quarters
|
|
|
CVGW
4139
DELISTED
Calavo Growers
CVGW
| $396K | ﹤0.01% |
14,899
-27,785
| -65% | -$726K |
2024 Q4
2 quarters
|
|
4140
TaskUs
TASK
$757M
| $395K | ﹤0.01% |
23,575
-537
| -2% | -$8.18K |
2024 Q4
2 quarters
|
|
4141
Aclaris Therapeutics
ACRS
$649M
| $394K | ﹤0.01% |
277,259
+26,454
| +11% | +$35.8K |
2024 Q4
2 quarters
|
|
4142
Under Armour
UAA
$1.99B
| $392K | ﹤0.01% |
57,409
+4,533
| +9% | +$28.2K |
2024 Q4
2 quarters
|
|
4143
Mayville Engineering Co
MEC
$400M
| $390K | ﹤0.01% |
24,447
+9,026
| +59% | +$129K |
2024 Q4
2 quarters
|
|
4144
CALL
Dow Inc
DOW
$19.9B
| $390K | ﹤0.01% |
+15,000
| New | +$436K |
2025 Q2
0 quarters
|
|
|
NMAY
4145
Innovator Growth-100 Power Buffer ETF - May
NMAY
$59.9M
| $389K | ﹤0.01% |
+14,775
| New | +$379K |
2025 Q2
0 quarters
|
|
4146
Schrodinger
SDGR
$2.28B
| $389K | ﹤0.01% |
19,341
-1,441
| -7% | -$32.9K |
2024 Q4
2 quarters
|
|
|
ITWO
4147
ProShares Russell 2000 High Income ETF
ITWO
$185M
| $389K | ﹤0.01% |
+10,674
| New | +$367K |
2025 Q2
0 quarters
|
|
4148
Sturm, Ruger & Co
RGR
$698M
| $388K | ﹤0.01% |
10,822
-101
| -0.9% | -$3.75K |
2024 Q4
2 quarters
|
|
4149
American Conservative Values ETF
ACVF
$153M
| $388K | ﹤0.01% |
8,219
+122
| +2% | +$5.35K |
2024 Q4
2 quarters
|
|
4150
Metallus
MTUS
$805M
| $387K | ﹤0.01% |
25,090
-602
| -2% | -$8.02K |
2024 Q4
2 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.